皓元医药
(688131)
| 流通市值：80.11亿 | | | 总市值：81.97亿 |
| 流通股本：2.06亿 | | | 总股本：2.11亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 497,446,645.4 | 442,230,962.84 | 445,315,659.88 | 483,611,131.37 |
| 应收票据及应收账款 | 585,226,098.92 | 565,075,630.25 | 542,216,666.76 | 457,064,371.67 |
| 其中：应收票据 | 15,228,405.74 | 7,561,927.92 | 14,399,071.29 | 7,233,899.11 |
| 应收账款 | 569,997,693.18 | 557,513,702.33 | 527,817,595.47 | 449,830,472.56 |
| 应收款项融资 | 9,880,643.75 | 7,028,199.04 | 1,522,990.55 | 14,232,794.61 |
| 预付款项 | 22,105,521.81 | 17,316,006.13 | 16,638,854.02 | 13,337,499 |
| 其他应收款合计 | 51,286,796.09 | 16,770,545.83 | 12,945,754.42 | 14,538,569.44 |
| 存货 | 1,151,625,343.23 | 1,101,699,839.46 | 1,159,862,781.66 | 1,145,471,760.05 |
| 合同资产 | 37,414,607.37 | 39,373,931.04 | 41,613,565.61 | 36,422,546.14 |
| 其他流动资产 | 21,894,931.13 | 38,364,339.75 | 22,576,295.93 | 23,587,033.59 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,376,880,587.7 | 2,227,859,454.34 | 2,242,692,568.83 | 2,188,265,705.87 |
| 非流动资产: | | | | |
| 长期股权投资 | 58,054,499.99 | 57,843,889.82 | 60,950,420.41 | 63,531,275.19 |
| 其他权益工具投资 | 69,863,796.74 | 66,958,761.04 | 54,885,594.56 | 54,821,107.66 |
| 其他非流动金融资产 | 13,000,000 | 13,000,000 | 13,000,000 | 13,000,000 |
| 固定资产 | 828,052,251.67 | 836,776,028.02 | 855,585,699.27 | 874,561,756.49 |
| 在建工程 | 264,636,567.05 | 279,589,080.82 | 229,306,374.57 | 152,134,793.27 |
| 使用权资产 | 362,325,876.43 | 193,190,104.94 | 171,317,910.94 | 179,361,024.8 |
| 无形资产 | 113,436,200.22 | 114,573,275.44 | 116,534,381.62 | 118,662,147.17 |
| 商誉 | 301,182,973.14 | 301,182,973.14 | 301,182,973.14 | 301,182,973.14 |
| 长期待摊费用 | 125,716,016.3 | 125,652,113.6 | 126,223,047.11 | 126,580,264.99 |
| 递延所得税资产 | 150,202,937.59 | 137,144,008.63 | 119,565,029.76 | 105,320,694.65 |
| 其他非流动资产 | 20,150,938.57 | 18,880,424.32 | 30,198,734.78 | 14,786,187.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,306,622,057.7 | 2,144,790,659.77 | 2,078,750,166.16 | 2,003,942,224.38 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,683,502,645.4 | 4,372,650,114.11 | 4,321,442,734.99 | 4,192,207,930.25 |
| 流动负债: | | | | |
| 短期借款 | 545,330,211.25 | 529,335,564.65 | 569,351,045.97 | 555,065,167.18 |
| 应付票据及应付账款 | 272,799,401.46 | 251,714,097.69 | 308,988,846.03 | 293,401,059.08 |
| 其中：应付票据 | 3,000,000 | 7,417,599.2 | 7,417,599.2 | 7,910,160 |
| 应付账款 | 269,799,401.46 | 244,296,498.49 | 301,571,246.83 | 285,490,899.08 |
| 合同负债 | 80,342,601.78 | 73,289,220.74 | 72,528,702.86 | 65,235,194.1 |
| 应付职工薪酬 | 108,913,008.95 | 99,257,800.25 | 109,369,775.86 | 99,434,180.59 |
| 应交税费 | 60,327,150.29 | 46,090,107.44 | 37,049,882.01 | 34,270,457.08 |
| 其他应付款合计 | 15,146,264.18 | 8,949,341.11 | 8,370,174.53 | 14,957,577.36 |
| 应付股利 | 8,437,155.36 | - | - | - |
| 一年内到期的非流动负债 | 113,446,336.74 | 120,312,583.94 | 85,518,230.29 | 94,177,932.38 |
| 其他流动负债 | 13,699,444.75 | 7,962,021.64 | 20,089,805.11 | 7,270,849.96 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,210,004,419.4 | 1,136,910,737.46 | 1,211,266,462.66 | 1,163,812,417.73 |
| 非流动负债: | | | | |
| 长期借款 | 287,874,064.16 | 288,374,064.16 | 283,115,235.13 | 229,231,497.63 |
| 租赁负债 | 347,979,379.85 | 180,998,942.81 | 159,697,112.65 | 168,863,965.88 |
| 长期应付款 | 41,399,039.22 | 47,517,853.3 | 27,642,965.04 | 27,329,660.42 |
| 递延收益 | 60,814,627.84 | 61,948,054.86 | 62,070,653.4 | 61,909,064.19 |
| 递延所得税负债 | 13,710,691.25 | 14,003,248.04 | 14,329,726.85 | 14,783,270.7 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 751,777,802.32 | 592,842,163.17 | 546,855,693.07 | 502,117,458.82 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,961,782,221.72 | 1,729,752,900.63 | 1,758,122,155.73 | 1,665,929,876.55 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 210,928,884 | 210,542,274 | 150,387,339 | 150,387,339 |
| 资本公积 | 1,682,612,351.93 | 1,665,579,271.64 | 1,705,472,330.06 | 1,688,885,173.03 |
| 其他综合收益 | 17,202,590.55 | 16,005,002.89 | 3,514,523.4 | 3,167,491.26 |
| 专项储备 | 5,258,068.4 | 5,439,988.97 | 4,558,415.5 | 3,469,792.33 |
| 盈余公积 | 19,496,653.59 | 19,496,653.59 | 19,496,653.59 | 19,496,653.59 |
| 未分配利润 | 768,681,134.66 | 704,178,005.46 | 660,429,705.61 | 643,672,354.15 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,704,179,683.13 | 2,621,241,196.55 | 2,543,858,967.16 | 2,509,078,803.36 |
| 少数股东权益 | 17,540,740.55 | 21,656,016.93 | 19,461,612.1 | 17,199,250.34 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,721,720,423.68 | 2,642,897,213.48 | 2,563,320,579.26 | 2,526,278,053.7 |
| 负债和股东权益合计 | 4,683,502,645.4 | 4,372,650,114.11 | 4,321,442,734.99 | 4,192,207,930.25 |
| 公告日期 | 2024-10-30 | 2024-08-29 | 2024-04-30 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |